Trial Profile
GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SeveX
- 12 Oct 2021 Status changed from active, no longer recruiting to completed.
- 09 Sep 2020 Status changed from recruiting to active, no longer recruiting.
- 09 Sep 2020 Planned End Date changed from 1 Sep 2020 to 1 Sep 2021.